My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies
sbend
>
Public
>
Public Works
>
Board of Works Documents
>
2025
>
Opening of Bids
>
Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/9/2025 2:33:46 PM
Creation date
9/9/2025 2:31:03 PM
Metadata
Fields
Template:
Board of Public Works
Document Type
Projects
Document Date
9/9/2025
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
87
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
Show annotations
View images
View plain text
Drugs and Alcohol), reasonable suspicion, return -to -duty, or follow-up (for Drugs and/or Alcohol). <br />Other tests may also be required under DOT's regulations or Company authority. The Company's <br />policy will direct whenever such other tests are required or permitted. The Company will notify an <br />applicant or employee of his/her test results only if the test is positive, or upon the written request of <br />the applicant or employee. <br />An applicant or employee who (1) tests positive (i.e., a verified positive <br />drug test or a positive alcohol test) on any drug or alcohol test required by this policy; (2) refuses to <br />submit to testing (see B-8), including failure to report for testing (except pre -employment, see <br />40.191(a)) within a reasonable time, as determined by the Company, consistent with FMCSA <br />regulations; or (3) fails to cooperate with testing procedures (e.g., to be escorted to or from a testing <br />site for a reasonable suspicion test) is prohibited from performing or continuing to perform any safety - <br />sensitive function for the Company (see B-9, for other consequences of violating this policy), and is <br />subject to disciplinary action up to and including discharge, solely at the option of the <br />Company. <br />The Company's policies, procedures, and requirements for each of these tests include (together <br />with the rest of this policy) the following: <br />a. pre-employment/pre-duty: [Ref 382.3011 <br />i. Drug testing is required before an applicant can be hired or transferred <br />into a position for which the Company requires the person to hold a CDL <br />and to operate (or be available to operate) a CMV for any purpose, or <br />to otherwise perform (or be available to perform) any safety -sensitive <br />function on behalf of the Company. Pre -employment alcohol testing <br />is not required by DOT regulations and not required by the Company. <br />ii. Employees will be provided educational materials, notification of the <br />required drug test and an explanation of the collection procedures through <br />the receipt of a copy of this policy. Applicants will likewise receive such <br />information, notification and instructions prior to pre -employment testing. <br />iii. The employee's signature on any custody and control form used with any <br />test requested under this policy will constitute his or her consent to be <br />tested and authorization to release any information permitted or required <br />by applicable Federal or State Regulations or Company policy. <br />iv. Applicants will be required to take and pass a drug test; authorize the <br />Company to obtain applicant's DOT -required drug and alcohol test results <br />(including refusals to be tested) from each company for whom s/he <br />worked (or applied for work) within the previous 3 years [Ref 391.23 (e)] ;and comply with <br />any other conditions or requirements of which s/he is advised in connection with the <br />position. <br />v. Driver/applicants will be required to register at the FMCSA clearinghouse <br />at https:/tclearinghouse.fmcsa.dot.gov/ and they must authorize per- <br />spective employers to run a full query pursuant to Part 382, Subpart G <br />[Ref 382.703]. <br />b. post -accident: [Ref 382.303] [See the Post -accident flow chart, p31.] <br />General. A covered employee who is subject to post -accident testing who fails to remain readily <br />available for such testing, including notifying a Company representative (e.g., the DER) of his/her <br />location if s/he leaves the scene of the accident prior to submission to such test, may be deemed by <br />the Company to have refused to submit to testing. This provision shall not be construed to require the <br />delay of necessary medical attention for injured people following an accident or to prohibit a covered <br />employee from leaving the scene of an accident for the period necessary to obtain assistance in <br />2020 Drug Screens Plus. All Rights Reserved. (11) FMCSA 20200101 266 <br />
The URL can be used to link to this page
Your browser does not support the video tag.